ESPR icon

Esperion Therapeutics

157 hedge funds and large institutions have $803M invested in Esperion Therapeutics in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less call options, than puts

Call options by funds: $ | Put options by funds: $

31% less capital invested

Capital invested by funds: $1.17B → $803M (-$364M)

35% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 26

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
157
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$11.6M
Puts
$15.1M
Net Calls
Net Calls Change

Top Buyers

1 +$41.3M
2 +$18.7M
3 +$18.1M
4
Morgan Stanley
Morgan Stanley
New York
+$5.22M
5
Citadel Advisors
Citadel Advisors
Florida
+$4.42M

Top Sellers

1 -$43.5M
2 -$23.7M
3 -$14.6M
4
BC
Boxer Capital
California
-$12.3M
5
AG
Artal Group
Luxembourg
-$9.29M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$134M
2
$104M
3
$69.7M
4
$65.6M
5
$61.5M
6
$53.7M
7
$40.6M
8
$35.8M
9
$15.4M
10
$13M
11
$12.9M
12
$11.7M
13
$10.6M
14
$9.86M
15
$9.71M
16
$8.46M
17
$8.06M
18
$7.66M
19
$7.53M
20
$6.96M
21
$6.12M
22
$5.39M
23
$5.37M
24
$4.78M
25
$4.71M